The originating document has been archived. We cannot confirm the completeness, accuracy and currency of the content.
In the US, Iodamide is a member of the drug class ionic iodinated contrast media.
ATC (Anatomical Therapeutic Chemical Classification)
CAS registry number (Chemical Abstracts Service)
Benzoic acid, 3-(acetylamino)-5-[(acetylamino)methyl]-2,4,6-triiodo-
- Iodamidum (Latin)
- Iodamid (German)
- Iodamide (French)
- Iodamida (Spanish)
- Iodamide (OS: BAN, JAN, USAN, DCIT, DCF)
- Ametriodinic acid (IS)
- SH 926 (IS)
- Iodamide (PH: JP XIV)
- Meglumine Sodium Iodamide Injection (OS: JAN)
- Meglumine Sodium Iodamide Injection (PH: JP XIV)
- Iodamide Meglumine (OS: USAN)
- Meglumine Iodamide Injection (OS: JAN)
- Iodamide, comp. with N-methylglucamine (IS)
- Radiomiro (IS)
- Rayomiro (IS)
- Triomiro (IS)
|BAN||British Approved Name|
|DCF||Dénomination Commune Française|
|DCIT||Denominazione Comune Italiana|
|JAN||Japanese Accepted Name|
|Rec.INN||Recommended International Nonproprietary Name (World Health Organization)|
|USAN||United States Adopted Name|
Click for further information on drug naming conventions and International Nonproprietary Names.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.